Dr. Isaac Tafur
Claim this profileJoe Arrington Cancer Research and Treatment Center
Studies Non-Small Cell Lung Cancer
Studies Cancer
7 reported clinical trials
12 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
metastatic
Stage IV
Stage III
2Cancer
metastatic
Stage IV
locally advanced
Affiliated Hospitals
Clinical Trials Isaac Tafur is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Tisotumab Vedotin
for Cancer
This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors and what side effects (unwanted effects) may occur. There are seven parts to this study. * In Part A, the treatment will be given to participants every 3 weeks (3-week cycles). * In Part B, participants will receive tisotumab vedotin on Days 1, 8, and 15 every 4-week cycle. * In Part C, participants will receive tisotumab vedotin on Days 1 and 15 of every 4-week cycle. * In Part D, participants will be given treatment on Day 1 of every 3-week cycle. Participants in Part D will get tisotumab vedotin with either: * Pembrolizumab or, * Pembrolizumab and carboplatin, or * Pembrolizumab and cisplatin * In Part E, participants will receive tisotumab vedotin on Days 1 and 15 of every 4-week cycle. * In Part F, participants will receive tisotumab vedotin on Days 1, 15, and 29 of every 6-week cycle. Participants in Part F will get tisotumab vedotin with pembrolizumab. * In Part G, participants will receive tisotumab vedotin on Days 1, 15, and 29 of every 6-week cycle. Participants in Part G will get tisotumab vedotin with pembrolizumab and carboplatin.
Recruiting1 award Phase 216 criteria
More about Isaac Tafur
Clinical Trial Related10 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Isaac Tafur has experience with
- Biospecimen Collection
- Pembrolizumab
- Crizotinib
- Questionnaire Administration
- Ladiratuzumab Vedotin
- Tisotumab Vedotin
Breakdown of trials Isaac Tafur has run
Non-Small Cell Lung Cancer
Cancer
Lung Cancer
Tumors
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Isaac Tafur specialize in?
Isaac Tafur focuses on Non-Small Cell Lung Cancer and Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved metastatic patients, or patients who are Stage IV.
Is Isaac Tafur currently recruiting for clinical trials?
Yes, Isaac Tafur is currently recruiting for 3 clinical trials in Lubbock Texas. If you're interested in participating, you should apply.
Are there any treatments that Isaac Tafur has studied deeply?
Yes, Isaac Tafur has studied treatments such as Biospecimen Collection, Pembrolizumab, Crizotinib.
What is the best way to schedule an appointment with Isaac Tafur?
Apply for one of the trials that Isaac Tafur is conducting.
What is the office address of Isaac Tafur?
The office of Isaac Tafur is located at: Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas 79410 United States. This is the address for their practice at the Joe Arrington Cancer Research and Treatment Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.